Cargando…

Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study

OBJECTIVES: Pro-protein convertase subtilisin/kexin 9 (PCSK9) decreases the clearance of the pathogenic lipids, supporting the potential role of PCSK9 in the prognosis of sepsis. METHODS: In this prospective cohort study, patients with sepsis were consecutively recruited from 1 to 2020 to 30 Septemb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shu, Yuanlu, Deng, Ziwei, Deng, Ye, Zhou, Jianliang, Wang, Jin, Duan, Zhenxing, Jiang, Tao, Zhao, Xiang, Shi, Zhihua, Qiu, Chengfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617046/ https://www.ncbi.nlm.nih.gov/pubmed/37904138 http://dx.doi.org/10.1186/s12873-023-00896-6

Ejemplares similares

Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials
por: Shu, Yuanlu, et al.
Publicado: (2021)

Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis
por: Li, Xing, et al.
Publicado: (2021)

PCSK9: A Potential Therapeutic Target for Sepsis
por: Yuan, Yuan, et al.
Publicado: (2020)

Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis [Corrigendum]
Publicado: (2021)

Lipid Lowering Therapy and Circulating PCSK9 Concentration
por: Nozue, Tsuyoshi
Publicado: (2017)

Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren
por: Azar, Yara, et al.
Publicado: (2022)

A Genetic Approach to the Association Between PCSK9 and Sepsis
por: Feng, QiPing, et al.
Publicado: (2019)

Circulating prekallikrein levels are correlated with lipid levels in the chinese population: a cross-sectional study
por: Shu, Yuanlu, et al.
Publicado: (2023)

Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012)

A Therapeutic Peptide Vaccine Against PCSK9
por: Pan, Yajie, et al.
Publicado: (2017)

PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells
por: Lagace, Thomas A.
Publicado: (2014)

The predictive utility of circulating PCSK9 levels on diabetes mellitus
por: Peng, Jia, et al.
Publicado: (2021)

Sex difference in circulating PCSK9 and its clinical implications
por: Jia, Fang, et al.
Publicado: (2022)

Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis
por: Kaur, Savneet, et al.
Publicado: (2021)

Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients
por: Tóth, Štefan, et al.
Publicado: (2017)

Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway
por: Laugsand, Lars E., et al.
Publicado: (2016)

Risk factors for 28-day mortality in patients with sepsis-related myocardial injury in intensive care units
por: Zhang, Meng, et al.
Publicado: (2021)

Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors
por: Genga, Kelly Roveran, et al.
Publicado: (2018)

A cohort study of routinely used sepsis biomarkers and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2013)

An immune-related gene signature predicts the 28-day mortality in patients with sepsis
por: Peng, Yaojun, et al.
Publicado: (2023)

Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a)
por: Zhang, Xiang, et al.
Publicado: (2020)

Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2020)

Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
por: Kuyama, Naoto, et al.
Publicado: (2021)

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study
por: Coggi, Daniela, et al.
Publicado: (2021)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Can heparin therapy reduce 28-day mortality in adult severe sepsis patients?
por: Jiang, Li-bing, et al.
Publicado: (2015)

Development and validation of immune dysfunction score to predict 28-day mortality of sepsis patients
por: Fang, Wen-Feng, et al.
Publicado: (2017)

High 28-day mortality in critically ill patients with sepsis and concomitant active cancer
por: Wang, Yong-gang, et al.
Publicado: (2018)

Neutrophil‐lymphocyte ratio and plasma lactate predict 28‐day mortality in patients with sepsis
por: Liu, Yunlong, et al.
Publicado: (2019)

The 28-Day Mortality Outcome of the Complete Hour-1 Sepsis Bundle in the Emergency Department
por: Prachanukool, Thidathit, et al.
Publicado: (2021)

1169. Derivation And Validation of an International Clinical Prognostication Model for 28-day Sepsis Mortality.
por: Blair, Paul W, et al.
Publicado: (2022)

Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6
por: Baldirà, Jaume, et al.
Publicado: (2023)

Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood
por: Peticca, Patricia, et al.
Publicado: (2013)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
por: Zhang, Zhong, et al.
Publicado: (2019)

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
por: Cao, Ye-Xuan, et al.
Publicado: (2019)

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)

Albumin-to-Fibrinogen Ratio Independently Predicts 28-Day Mortality in Patients with Peritonitis-Induced Sepsis
por: Tai, Huiyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5r6oaa6mv04cr164559gj86laa